Literature DB >> 20566735

The National Data Bank for rheumatic diseases: a multi-registry rheumatic disease data bank.

Frederick Wolfe1, Kaleb Michaud.   

Abstract

The National Data Bank (NDB) for rheumatic diseases is a patient-based multi-disease, multi-purpose rheumatic disease registry that has been used primarily to study patients with RA, SLE, FM and OA. It enrols patients from the community, follows up with questionnaires and validates key patient data using medical records. Rheumatologist-written programs make NDB data immediately available to analysts. The NDB has been used to develop and validate diagnostic criteria, develop new questionnaires, describe illness and comorbid disease, assesses disease outcomes and the effect of therapeutic interventions, and measure costs and cost-effectiveness.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20566735     DOI: 10.1093/rheumatology/keq155

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  33 in total

1.  Improving the pharmacologic management of pain in older adults: identifying the research gaps and methods to address them.

Authors:  M Cary Reid; David A Bennett; Wen G Chen; Basil A Eldadah; John T Farrar; Bruce Ferrell; Rollin M Gallagher; Joseph T Hanlon; Keela Herr; Susan D Horn; Charles E Inturrisi; Salma Lemtouni; Yu Woody Lin; Kaleb Michaud; R Sean Morrison; Tuhina Neogi; Linda L Porter; Daniel H Solomon; Michael Von Korff; Karen Weiss; James Witter; Kevin L Zacharoff
Journal:  Pain Med       Date:  2011-08-11       Impact factor: 3.750

2.  Construction of a US fibromyalgia registry using the Fibromyalgia Research Survey criteria.

Authors:  Mary O Whipple; Samantha J McAllister; Terry H Oh; Connie A Luedtke; Loren L Toussaint; Ann Vincent
Journal:  Clin Transl Sci       Date:  2013-04-19       Impact factor: 4.689

3.  Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods.

Authors:  Mónica Hernández Alava; Allan Wailoo; Stephen Pudney; Laura Gray; Andrea Manca
Journal:  Health Technol Assess       Date:  2020-06       Impact factor: 4.014

4.  Association of valine and leucine at HLA-DRB1 position 11 with radiographic progression in rheumatoid arthritis, independent of the shared epitope alleles but not independent of anti-citrullinated protein antibodies.

Authors:  H W van Steenbergen; S Raychaudhuri; L Rodríguez-Rodríguez; S Rantapää-Dahlqvist; E Berglin; R E M Toes; T W J Huizinga; B Fernández-Gutiérrez; P K Gregersen; A H M van der Helm-van Mil
Journal:  Arthritis Rheumatol       Date:  2015-04       Impact factor: 10.995

5.  The Use of Polysymptomatic Distress Categories in the Evaluation of Fibromyalgia (FM) and FM Severity.

Authors:  Frederick Wolfe; Brian T Walitt; Johannes J Rasker; Robert S Katz; Winfried Häuser
Journal:  J Rheumatol       Date:  2015-06-15       Impact factor: 4.666

6.  Effect of Missed Doses on the Therapeutic Effect of Methotrexate for Rheumatoid Arthritis: A Pharmacokinetic Modeling Study.

Authors:  Alan Morrison; Melissa E Stauffer; Anna S Kaufman
Journal:  Open Access Rheumatol       Date:  2021-09-14

7.  Utilization of Care Outside the Veterans Affairs Health Care System by US Veterans With Rheumatoid Arthritis.

Authors:  Pascale Schwab; Harlan Sayles; Debra Bergman; Grant W Cannon; Kaleb Michaud; Ted R Mikuls; Jennifer Barton
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-05-09       Impact factor: 4.794

8.  Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritis.

Authors:  Frederick Wolfe; Marcy B Bolster; Christopher M O'Connor; Kaleb Michaud; Kenneth W Lyles; Cathleen S Colón-Emeric
Journal:  J Bone Miner Res       Date:  2013-05       Impact factor: 6.741

9.  Changes in Disease-Modifying Antirheumatic Drug Treatment for Patients With Rheumatoid Arthritis in the US During the COVID-19 Pandemic: A Three-Month Observational Study.

Authors:  Kaleb Michaud; Sofia Pedro; Kristin Wipfler; Ekta Agarwal; Patricia Katz
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-08-06       Impact factor: 5.178

10.  Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects.

Authors:  Christopher J Smith; Harlan Sayles; Ted R Mikuls; Kaleb Michaud
Journal:  Arthritis Res Ther       Date:  2011-10-18       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.